SU2C Community Engagement Grants
Craig Tendler
![Craig Tendler]()
Craig Tendler
Vice President Oncology Clinical Development, Diagnostics, & Global Medical Affairs at Johnson and Johnson (Retired)
At Johnson & Johnson Innovative Medicine, we believe collaboration is essential to make #Cancer a preventable and curable disease.
That’s why we’re particularly proud to sponsor Stand Up to Cancer, who recently awarded seven community organizations with grants to fund efforts to increase #Diversity in early phase cancer #ClinicalTrials, as part of their Diversity In Early Development Clinical Trials Program announced earlier this year.
?These efforts will be critical in our ambition to get in front of cancer for all patients. https://bit.ly/3Rx2rLZ
?
#MyCompany #CancerResearch #HealthEquity #JNJOncology